Drug Shortage Report for NOLVADEX-D TAB 20MG

Last updated on 2020-06-18 History
Report ID 94235
Drug Identification Number 02048485
Brand name NOLVADEX-D TAB 20MG
Common or Proper name tamoxifen citrate
Company Name ASTRAZENECA CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TAMOXIFEN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 x 30
ATC code L02BA
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-26
Actual start date 2019-09-26
Estimated end date 2020-06-30
Actual end date 2020-05-21
Shortage status Resolved
Updated date 2020-06-18
Company comments Limited supply available
Health Canada comments
Tier 3 Status No
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-09-18 English Compare
v2 2019-09-18 French Compare
v3 2019-09-20 English Compare
v4 2019-09-20 French Compare
v5 2019-09-26 English Compare
v6 2019-09-26 French Compare
v7 2019-09-27 English Compare
v8 2019-10-31 English Compare
v9 2019-10-31 French Compare
v10 2019-11-15 English Compare
v11 2019-11-15 French Compare
v12 2019-12-06 English Compare
v13 2019-12-06 French Compare
v14 2020-06-18 English Compare
v15 2020-06-18 French Compare

Showing 1 to 15 of 15